How M.D. was paid
$7.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Jeffrey M. Dayno, M.D.President and Chief Executive Officer | $743,600 | — | $1,976,520 | $4,599,000 | $558,000 | $22,415 | $7,899,535 |
| Sandip KapadiaEVP and Chief Financial Officer and Chief Administrative Officer | $522,834 | — | $718,389 | $1,692,688 | $248,346 | $22,062 | $3,204,319 |
| Adam ZaeskeEVP and Chief Commercial Officer | $376,923 | $200,000 | $852,000 | $1,866,000 | $189,041 | $180,264 | $3,664,228 |
| Kumar BudurEVP and Chief Medical & Scientific Officer | $598,000 | — | $404,807 | $955,570 | $299,000 | $22,062 | $2,279,439 |
| Andrew SerafinEVP, Chief Strategy Officer | $439,208 | — | $395,304 | $932,575 | $219,605 | $22,585 | $2,009,277 |
| Jeffrey DierksFormer EVP and Chief Commercial Officer | $132,263 | — | $511,235 | $1,205,960 | — | $497,487 | $2,346,945 |
What changed and why
- $7.9MCEO Jeffrey M. Dayno total compensation increased to $7,899,535 in fiscal 2025.
- The ratio of CEO to median employee compensation was 26 to 1.
- Adam Zaeske joined as EVP and Chief Commercial Officer with a sign-on bonus.
- 97.6%Stockholders previously showed 97.6% support for say-on-pay at the 2023 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.